Resultados de procura - B Dupont

Limitar resultados
  1. 1
    Overview of the lipid formulations of amphotericin B

    Overview of the lipid formulations of amphotericin B por B. Dupont

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Renal impairment and Amphotericin B formulations in patients with invasive fungal infections

    Renal impairment and Amphotericin B formulations in patients with invasive fungal infections por Faouzi Saliba, B. Dupont

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Antifungal prophylaxis during neutropenia and immunodeficiency

    Antifungal prophylaxis during neutropenia and immunodeficiency por Olivier Lortholary, B. Dupont

    Publicado 1997
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Epidemiology of Cryptococcosis in France: A 9-Year Survey (1985-1993)

    Epidemiology of Cryptococcosis in France: A 9-Year Survey (1985-1993) por Françoise Dromer, S. Mathoulin, B. Dupont, Anne Laporte

    Publicado 1996
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide

    Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide por Françoise Dromer, E. Guého, O. Ronin, B. Dupont

    Publicado 1993
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation.

    Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation. por Perrin C. White, Maria I. New, B Dupont

    Publicado 1984
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole

    Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole por Emmanuelle Bart–Delabesse, Patrick Boiron, A. Carlotti, B. Dupont

    Publicado 1993
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Molecular typing of Cryptococcus neoformans serotype D clinical isolates

    Molecular typing of Cryptococcus neoformans serotype D clinical isolates por Françoise Dromer, Ashok Varma, O. Ronin, S. Mathoulin, B. Dupont

    Publicado 1994
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Voriconazole Treatment for Subacute Invasive and Chronic Pulmonary Aspergillosis

    Voriconazole Treatment for Subacute Invasive and Chronic Pulmonary Aspergillosis por Helen Sambatakou, B. Dupont, H. Lode, David W. Denning

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Comparison of the Efficacy of Amphotericin B and Fluconazole in the Treatment of Cryptococcosis in Human Immunodeficiency Virus-Negative Patients: Retrospective Analysis of 83 Cases

    Comparison of the Efficacy of Amphotericin B and Fluconazole in the Treatment of Cryptococcosis in Human Immunodeficiency Virus-Negative Patients: Retrospective Analysis of 83 Case... por Françoise Dromer, S. Mathoulin, B. Dupont, Olivier Brugière, Luc Letenneur

    Publicado 1996
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Individual and Environmental Factors Associated with Infection Due to Cryptococcus neoformans Serotype D

    Individual and Environmental Factors Associated with Infection Due to Cryptococcus neoformans Serotype D por Françoise Dromer, S. Mathoulin, B. Dupont, Luc Letenneur, O. Ronin

    Publicado 1996
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B

    Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B por B. Dupont, Olivier Lortholary, Luis Ostrosky‐Zeichner, Flavie Stucker, Vijay Yeldandi

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Primary Cutaneous Cryptococcosis: A Distinct Clinical Entity

    Primary Cutaneous Cryptococcosis: A Distinct Clinical Entity por Ségolène Neuville, Françoise Dromer, Odile Morin, B. Dupont, O. Ronin, Olivier Lortholary

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Epidemiology of HIV-associated cryptococcosis in France (1985–2001)

    Epidemiology of HIV-associated cryptococcosis in France (1985–2001) por Françoise Dromer, Simone Mathoulin‐Pélissier, Arnaud Fontanet, O. Ronin, B. Dupont, Olivier Lortholary

    Publicado 2004
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Adjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis

    Adjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis por Faézeh Legrand, Marc Lecuit, B. Dupont, Erianna Bellaton, Michel Huerre, Pierre‐Simon Rohrlich, O. Lortholary

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Voriconazole for Invasive Bone Aspergillosis: A Worldwide Experience of 20 Cases

    Voriconazole for Invasive Bone Aspergillosis: A Worldwide Experience of 20 Cases por H. Mouas, Irja Lutsar, B. Dupont, O. Fain, Raoul Herbrecht, François-Xavier Lescure, Olivier Lortholary

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials

    Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials por Márcio Nucci, Robert F. Betts, B. Dupont, Chien‐Sheng Wu, Donald N. Buell, Laura Kovanda, Olivier Lortholary

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

    Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials por Márcio Nucci, Elias Anaissie, Robert F. Betts, B. Dupont, Chunzhang Wu, Donald N. Buell, Laura Kovanda, Olivier Lortholary

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Reply to Koh and Luong and to Shaked et al

    Reply to Koh and Luong and to Shaked et al por Márcio Nucci, Elias Anaissie, Robert F. Betts, B. Dupont, Chunzhang Wu, Donald N. Buell, Laura Kovanda, Olivier Lortholary

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

    A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients por R. Ally, Dirk Schürmann, Wolfgang Kreisel, Giampiero Carosi, Koldo Aguirrebengoa, B. Dupont, Michael R. Hodges, Peter F. Troke, Alain Romero

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: